Skip to content



California HIV/AIDS Research Program Awards $2.4 Million to Local Researchers with Basic Biomedical Discovery Initiative

December 5, 2019: CHRP awarded nine new grants to researchers at non-profit institutions across the state. More information about these project is available here.


Focus on Youth Living with HIV: Food insecurity and depression impair treatment adherence; telehealth counseling with youth can help

December 5, 2019: Drs. Parya Saberi and Carol Dawson Rose and their team are in the fourth year of their CHRP HIV and Health Disparities award and have already published four manuscripts from their research with youth living with HIV (YLWH). Read the full story here.


Basic Biomedical Sciences Discovery Initiative 2019

April 8, 2019: CHRP released our Call for Applications today. More information here


CHRP Welcomes Dr. Andrew Forsyth

February 1, 2019: Dr. Andrew Forsyth has assumed the position of CHRP Director following the retirement of Dr. George Lemp. Dr. Forsyth comes to us from Washington, D.C., where he served as the Director for the Office of Research and Science at the State Department’s Office of the Global AIDS Coordinator, which oversees the $6 billion President’s Emergency Plan for AIDS Relief (PEPFAR). In that capacity, he endeavored to harness lessons from research to improve programs; highlighted scientific advances made possible by PEPFAR funding; and helped to influence policy, funding decisions, and program implementation to accelerate HIV epidemic control in Botswana, Nigeria, and Tanzania.

Prior to this, Dr. Forsyth served as a Senior Science Officer in the Health and Human Services (HHS) Office of HIV/AIDS and Infectious Disease Policy, where he led departmental and White House working groups to achieve the goals of the National HIV/AIDS Strategy and the HIV Care Continuum Initiative. He launched and oversaw cross-agency efforts to streamline data collection, reduce reporting obligations for grantees, and develop data standards and outcome indicators. He also actively engaged a diverse range of federal and non-federal stakeholders in efforts to improve data reporting obligations.

Dr. Forsyth also spent nine years as a program officer developing and managing a $40 million prevention science portfolio at the National Institute of Mental Health’s (NIMH) Division of AIDS Research. In this capacity, he worked closely with new and established HIV scientists; managed a subset of NIMH’s research centers (including some of CHRP’s currently funded organized research groups); and served as a scientific liaison to several large HIV clinical trials networks for vaccines, microbicides, adolescent medicine, and HIV prevention that were supported in collaboration with other NIH Institutes and Centers.

Dr. Forsyth received a Ph.D. in clinical health psychology from Syracuse University, and completed a post-doctoral fellowship with emphases in public health, research methodology, and statistics at the University of California, San Francisco.

Dr. Forsyth’s passion for public health, experience working effectively with policy makers and advocates, and HIV science expertise will make him an effective spokesperson for CHRP and health research in California.


New California-Based Funding for Research on Rapid Initiation of HIV Treatment and Big Data HIV Surveillance

April 17, 2018: CHRP funded four projects in our latest initiative, One Step Ahead: An Open Call for Highly Visionary Investigator-Initiated HIV Research in California. The four awards have a combined funding total of $7.5 million over a four-year period, and each takes a different approach to addressing an important aspect of the HIV epidemic. Learn about each of the funded projects here.


California HIV/AIDS Research Program Cure Initiative special issue in AIDS Research and Human Retroviruses. 

November 15, 2017: We are pleased to release an open access special issue on our Cure Initiative in the journal AIDS Research and Human Retroviruses. Access all the articles here


CHRP's TransPrEP! Project:  HIV Prevention by and for the Transgender Community in California

November 13, 2017: The California HIV/AIDS Research Program (CHRP) is proud to be funding the largest demonstration project of its kind in the U.S., to determine the efficacy, acceptability, and pharmacokinetics of HIV pre-exposure prophylaxis (PrEP) medication among transgender persons.  CHRP has invested $9.4 million in three research studies across the state, recognizing that the people in the transgender community deserve dedicated and substantial resources to promote their health and protect their lives. The studies each use different techniques, such as providing PrEP and hormonal therapy together at a single clinic visit, or an in-depth pharmacokinetic analysis to determine whether the two treatments interact, or a custom text messaging app to communicate with providers and peer support. In the video, researchers, consumers, and health care providers offer their perspectives on why this research is important, and how members of the community can participate.  View the video here.


"Finding Hidden and Lost HIV Patients in Los Angeles County: Mining Social Networks to Approach and Engage Them in Care" 

June 26,2017: Sprinkled among every community are people who seem to know everyone. Influential and connected, they're the nexus of large and invisible social circles. Those are the people, realized Dr. Amy Rock Wohl, who may be able to help slow the spread of HIV in hard-to-reach populations – by linking their friends to care.


“Drink Like a Barman” for Better Sexual Health? 

December 14, 2016: When bars offered self-service drinking water, breathalyzers showed lower blood alcohol content among patrons. Results could help HIV prevention efforts.


New Report Examines Annual PrEP Costs Through Covered California 

November 1, 2016: The Southern California HIV Policy Research Center today released a new policy brief that will help consumers better understand the cost of accessing pre-exposure prophylaxis (PrEP) through Covered California health plans. Open enrollment for Covered California, the State’s health insurance marketplace, begins today.


The California HIV/AIDS Policy Research Centers Announce Inaugural Policy Research Fellows Program

November 1, 2016: The Fellows Program provides policy research training and education to individuals who are affiliated with HIV/AIDS community-based organizations in California that serve people living with or populations disproportionately affected by HIV/AIDS. The two-year fellowship program will increase the capacity of community-based organizations to address the HIV epidemic in California by shaping public policy.


APLA Health Releases New Report Showing Significant Disparities in PrEP Awareness and Use Among Young Gay and Bisexual Men in California Majority

September 12, 2016: Majority of participants in a statewide survey were interested in taking PrEP, but less than 10% had ever used it; black and Latino men faced more barriers to accessing PrEP


"The homeless young man is the most unlikely of HIV educators..."

June 28, 2016: CHRP announcess disparities grants


Including Robyn: Does HIV PrEP help transgender people?

April 25, 2016: UC launches first culturally-appropriate PrEP demonstration project in the U.S.


An HIV prevention pill for transgender persons: UC launches three trials

April 25, 2016: UC launches first in the nation demonstration project


New patient care model reduces hospital re-admission rates

May 5, 2014

A demonstration project aimed at improving patient care for people with HIV and AIDS has reduced the number of hospital re-admissions at one Bay Area hospital by 44 percent. The new approach puts primary care physicians at the helm of an integrated care team that includes social workers, psychologists and medical specialists. These collaborative teams form virtual "patient-centered medical homes" that work together to ensure that patients come to appointments, take their medications and get the care they need.


Harm-reduction program optimized HIV/AIDS prevention, USCF study shows
April 18, 2014 

New research from UC San Francisco and the San Francisco AIDS Foundation has found that clients participating in a harm-reduction substance use treatment program, the Stonewall Project, decrease their use of stimulants, such as methamphetamine, and reduce their sexual risk behavior.


HIV: New East Bay program gives prevention pill to high-risk youths
July 15, 2013

The number of people nationwide who are newly infected with HIV, the virus that can cause AIDS, has held steady at about 50,000 annually in recent years after dropping sharply in the late 1980s, despite health professionals' best efforts to tackle the problem. "There is a degree of frustration -- we don't seem to be able to reduce the level of transmission," said George Lemp, director of the California HIV/AIDS Research Program. "A lot of people felt that we needed more aggressive approaches." The program will award $18 million in grants over four years to teams in Oakland, Los Angeles and San Diego to test a new approach that includes distributing Truvada to high-risk groups.


East Bay Renew Efforts To Reduce HIV Infection
June 20, 2013

Oakland is ground zero for an ambitious effort aimed at reducing the rate of HIV infection in young gay men of color. Clinical trials are underway of an FDA-approved therapy for prevention of HIV infection. Since January of 2010 the Downtown Youth Clinic has kept busy. The daily anti-retroviral medication is Truvada by Gilead, which was approved last year by the FDA. The California HIV/AIDS research program is funding the service.


2012 Journal publications from CHRP-funded research (pdf)


Researchers identify possible key to slow progression toward AIDS
September 19, 2012

One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all. Even among those with the B57 gene, the speed of disease progression can vary considerably. Now, a group of investigators from the Multi-Center AIDS Cohort Study (MACS), housed within the UCLA AIDS Institute, may have uncovered the key to this variation.


California to test HIV-prevention pill
April 17, 2012

California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state. The pill, which is already used to treat HIV patients, will be prescribed to 700 gay and bisexual men and transgender women in Los Angeles, San Diego and Long Beach who are high-risk but not infected. "With this new prevention pill, we have another intervention to put in the arsenal to try and impact this epidemic," said George Lemp, director of the California HIV/AIDS Research Program with the UC president's office.


Considering TLC+ In California: Proceedings of a Think Tank on HIV Testing, Linkage to Care, Plus Treatment
Nov. 10, 2010

In May 2010, the California HIV/AIDS Research Program (CHRP) and the California Coalition of Local AIDS Directors (CCLAD) co-sponsored a statewide think tank called Considering TLC+ in California. The specific goals of TLC+ (Testing and Linkage to Care Plus Treatment) are twofold: to increase the number of HIV-positive people who know their serostatus and are engaged in care and treatment to improve their individual health outcomes and to reduce the incidence of HIV infection.

Sixty-four planners, policymakers, treatment and care providers attended the meeting. TLC+proceedings report (pdf)